Fibrolamellar hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports

BACKGROUND: Fibrolamellar hepatocellular carcinoma is a unique tumor of the liver that differs from the classical hepatocellular carcinoma in diagnosis, behavior, and possibly treatment. There is usually absent underlying liver disease, and it usually occurs in young patients. The survival outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: AL Zahrani, Ali, Alfakeeh, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962306/
https://www.ncbi.nlm.nih.gov/pubmed/33722275
http://dx.doi.org/10.1186/s13256-021-02695-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962306/
https://www.ncbi.nlm.nih.gov/pubmed/33722275
http://dx.doi.org/10.1186/s13256-021-02695-8

Ejemplares similares